baber/WOPTO huggingface dataset:
Patent NZ-335466-A (NZ)
Title: Window frame extrusion, overshelf protrudes beyond lip of sealing strip channel to hide sealing strip from view
Inventor: O'SULLIVAN SEAN FRANCIS
IPC: E06B3/16
Filed: 1999-04-28
Abstract: An extrusion for supporting a glazing panel 2 includes a channel for a sealing strip 1.  An overshelf 3 extends beyond the edge of the channel.  This hides the sealing strip from view.  The other side of the panel 1 may supported conventionally by a wedge.  The overshelf may be angled to the surface of the panel 1, as shown,  or may  be at right angles to the panel.
Patent NZ-502123-A (NZ)
Title: Biodegradable mineral wool composition for use as a thermal and/or noise insulation product
Inventor: DE MERINGO ALAIN
IPC: C03C13/00
Filed: 1999-05-04
Abstract: A biodegradable mineral wool comprising the following constituents, in percentages by weight: SiO2  38-52%, preferably 40-48% Al2O3  17-23% SiO2 + Al2O3  56-75, preferably 62-72% RO (CaO + MgO)  9-26%, preferably 12-25% MgO  4-20%, especially 7-16% MgO/CaO  ³ 0.8, preferably ³ 1.0 or ³ 1.15 R2O (Na2O + K2O)  ³ 2% P2O5  0-5% Fe2O3 (total iron) > 1.7% B2O3  0-5% MnO  0-4% TiO2  0-3% And the R2O and Al2O3 contents satisfy the relationship 0.2 >= R2O/Al2O3 >= 0.8.
Patent NZ-502853-A (NZ)
Title: Treatment of conduct disorder with a norepinephrine reuptake inhibitor such as tomoxetine
Inventor: HEILIGENSTEIN JOHN HARRISON
IPC: A61K31/5375
Filed: 1998-09-01
Abstract: Norepinephrine reuptake inhibitor such as tomoxetine, reboxetine, duloxetine, venlafaxine, milnacipran and a compound of formula I, where X is C1 to C4 alkylthio, and Y is C1-C2 alkyl or a pharmaceutically acceptable salt, is used to treat conduct disorder.
Patent NZ-504182-A (NZ)
Title: Cellular phone operated vending machine
Inventor: STEWEN TEEMU
IPC: G07F7/08
Filed: 1998-10-29
Abstract: A cellular telephone or similar device is used to access a telecommunication network, which includes an intelligent network. The intelligent network contains means for determining location and charge data, producing voicemail messages and connecting to a control center. The control center is part of a second device (i.e. vending machine), which can at the request of the intelligent network deliver goods or services. The control center is also able to communicate information to the intelligent network about the state of the machine. So a cellular telephone user may request and be charged for a particular goods or service from a vending machine by dialing a particular number, the goods or service then being delivered to a vending machine in close proximity to the user.
Patent NZ-504382-A (NZ)
Title: Switch mechanism for toaster, switch operated by lever pivoted at one end
Inventor: HUGGLER PETER
IPC: A47J37/08
Filed: 2000-05-08
Abstract: In an electric toaster, movement of a bread carriage 247 works a lever 202 to activate the heating elements and timer.  The lever is pivoted at 246, so that when arm 236 is depressed by downwards movement of the carriage, contacts 239, 240 are moved into contact with contacts 241, 242 to supply power to the heating elements and timer.  The lever is movable between a released position, as shown in Figure 6A, and a toasting position as shown in Figure 6C.  The electromagnet 243 attracts the keeper 245 on the end of arm 236 to hold the lever in the toasting position.    The other end of the lever includes a retainer 252, which holds the carriage 247 in place once the lever has reached the toasting position.  When the toasting cycle is complete, the electromagnet is de-energized and releases lever 202.  This allows spring 258 to pull the carriage upwards, and opens the contacts 239, 240, and 241, 242.  If the carriage jams, as shown in figure 6D, then the lever still moves back to its released position, cutting power to the elements.  This avoids the possibility of bread being jammed in the toaster with the elements still operating.
Patent NZ-505652-A (NZ)
Title: Method for treating fibrous webs
Inventor: AHONEN HEIKKI
IPC: D21G1/00
Filed: 1999-01-11
Abstract: The present invention concerns a method for treating the surface of a fibrous web by mechanical grinding. According to the invention, the grinding is performed at substantially dry state by removing only the higher parts of the paper surface without substantially increasing the density of the web. By reducing the roughness of the surface by a maximum of 90 %, the strength properties of the web remain essentially unchanged or they are even improved. Thus, when the roughness of the surface is reduced by about 40 to 60 %, the tear strength increases with more than 5 % in comparison to an untreated web. Papers and boards treated by the present method can be used for printing, packaging and wrapping.
Patent NZ-510376-A (NZ)
Title: Inhibition of toxic materials or substances, including peptides, proteins and polyamines, using dendrimers
Inventor: HOLAN GEORGE
IPC: A61P39/02
Filed: 1999-09-13
Abstract: Described is the use in the manufacture of a medicament for prophylactic or therapeutic inhibition of a toxic material or substance in a human or non-human animal patient, a dendrimer having a plurality of terminal groups wherein at least one of the terminal groups has an anionic- or cationic-containing moiety bonded or linked thereto.
Patent NZ-510395-A (NZ)
Title: Hepatitis C inhibitor peptides
Inventor: TSANTRIZOS YOULA S
IPC: H01Q21/06
Filed: 1999-08-09
Abstract: Disclosed is a compound of Formula (I), wherein a is 0 or 1; b is 0 or 1; Y is H or C1-6 alkyl; B is H, an acyl derivative or a sulphonyl derivative; W is hydroxy or a N-substituted amino; or a pharmaceutically acceptable salt or ester thereof. Such compounds are useful in the treatment of hepatitis C virus ( HCV ) infection.
Patent NZ-516644-A (NZ)
Title: Integral concrete wall forming system
Inventor: LONG ROBERT T
IPC: E04C2/04
Filed: 2000-06-16
Abstract: A method for making a hollow concrete wall panel 12 involves pouring a first concrete layer 14 into a form. An insulation layer 18 is then supported above the first concrete layer so as to create a space. A second concrete layer 16 is then poured on top of the insulation layer before the first concrete layer has cured. Connectors 20 are anchored in the first and second concrete layers so as to tie the layers together. The first and second concrete layers cure simultaneously, after which the wall panels can be lifted, transported, and assembled into a wall structure. An intermediate layer of concrete can be poured into the air gap of the wall panels such that the panels define the form for the intermediate concrete layer and become an integral part of the wall structure. The edges of the wall panels are also preferably contoured so as to interlockingly engage with a corresponding contoured edge of an adjacent wall panel.
Patent NZ-517177-A (NZ)
Title: 9-Furanyl, cyclopentyl or thienyl purine derivatives useful for treating ischemia or hypoxia
Inventor: MASAMUNE HIROKO
IPC: A61K31/616
Filed: 2000-09-22
Abstract: A purine derivative or a prodrug or salt thereof has the formula (I) wherein: X is oxy, methylene or thio; Y is CH or N; Z is H, alkyl, alkyloxy, trifluoromethyl or halo; R1 is hydroxymethyl, alkoxymethyl, cycloalkoxymethyl, carboxy, alkoxycarbonyl, cycloalkoxycarbonyl, 1,1- aminoiminomethyl, 1,1-(mono-N- or di-N,N-alkylamino)- iminomethyl, 1,1-(mono-N- or di-N,N-cycloalkylamino)- iminomethyl, carbamoyl, mono-N- or di-N,N- alkylaminocarbonyl, mono-N- or di-N,N- cycloalkylaminocarbonyl, N-alkyl-N-cycloalkylaminocarbonyl; R2 is H, alkyl or cycloalkyl; R3 is halo, trifluoromethyl, cyano, alkyl, alkyloxy, ethenyl or ethynyl; D is oxy, thio, alkyloxy, alkylthio or alkylamino; G is a optionally saturated optionally substituted 5 to 8 membered ring or a bicyclic ring consisting of two fused 3 to 6 membered rings optionally containing 1 to 4 heteroatoms selected from N, O or S or G is cyano, tetrazolyl, alkoxycarbonyl, cycloalkoxycarbonyl, C(O)NR4R5, C(S)NR4R5, C(NH)NR4R5, C(N-alkyl)-NR4R5 or C(N- cycloalkyl)NR4R5 and R4 and R5 are as defined in the specification. The compounds are useful as A-3 receptor agonists for treating ischemia or hypoxia.
Patent NZ-521042-A (NZ)
Title: Coating of porus articles with antibiotics by providing an aqueous solution of the antibiotic, then an aqueous solution containing an amphiphilic component, forming a sparingly water-soluable deposit
Inventor: VOGT SEBASTIAN
IPC: A61F2/28
Filed: 2002-08-27
Abstract: A method of antibiotic coating non-metallic bodies with interconnecting microhollows is described.   The  method  is characterised  in that an aqueous solution 1  is  introduced into  the  microhollows of nonmetallic bodies, the  solution containing  at  least  one readily water-soluble  antibiotic component   selected   from   the   group   consisting    of aminoglycoside   antibiotics,   tetracycline    antibiotics, linosamide antibiotics and the 4-chinolone antibiotics,  and a  aqueous solution 2 containing at least one water  soluble amphiphilic  component selected from the  groups  consisting of  alkyl  sulfates, alkyl sulfonates. alkyl aryl  sulfates, dialkyl  aryl sulfates, alkyl aryl sulfonates, dialkyl  aryl sulfonates   cycloalkyl  sulfates,  cycloalkyl   sulfonates, alkyl  cycloalkyl  sulfates, with  water  being  essentially removed  by  vaporization and/or volatilization between  the introduction  of  solutions 1 and 2 with a sparingly  water- soluble precipitate from the components of solutions  1  and 2 being formed in the microhollows.
Patent NZ-522177-A (NZ)
Title: Electrostatic spray equipment with grounding means and means for determining spraying distance
Inventor: BARRON BRADFORD SCOTT
IPC: D06F73/00
Filed: 2001-05-23
Abstract: A method and equipment for applying a liquid product onto a household article or plant for purpose of cleaning, wetting, coating, polishing, fabric treatment, plant watering and the like, the method comprising discharging the liquid through a spray nozzle (3) in the form of an upwardly or downwardly directed spray of droplets having an average droplet size of at least about 40 mm and preferably in the range from about 75 to about 500 mm and at a proximal distance of from about 0.1 to about 1 m from the household article or plant, the liquid being discharged through the spray nozzle at an exit velocity in the range from about 3 to about 80 m/s, preferably from about 3 to about 20 m/s (when the spray droplets are upwardly directed) and from about 0 to about 2 m/s (when the spray droplets are downwardly directed) and at an applied potential in the range from about 0.2 to about 50 kV, whereby the overspray is less than about 40 %. The equipment preferably comprises a nozzle having a multi-jet spray head, means (7) for adjusting the orientation of the nozzle and grounding means (not shown) for charge dissipation. The method and equipment provide effective coverage of household objects/plants and avoid spoil and waste of the liquid in the surroundings of the household object/plant.
Patent NZ-523024-A (NZ)
Title: Method for preparing a composition by expansion without boiling
Inventor: BUSSON PATRICK
IPC: A61K47/26
Filed: 2001-06-18
Abstract: A method for the preparation of a pharmaceutical composition comprises the steps of : (a) preparing a solution or a homogenous dispersion of a liquid and a compound selected from the group consisting of one or more pharmaceutically active compounds, one or more pharmaceutically suitable excipient and mixtures thereof followed by (b) expansion of the solution of homogenous dispersion by exposing it to s reduction in pressure to between about 30 and 150 Torr under condition such that the solution of homogenous dispersion does not boil ; and (c) stabilization of the expanded solution or homogenous dispersion to form the pharmaceutical composition. Also described are pharmaceutical composition in the form of a coherent lamellar, foam-, sponge- or cake-like structure composition comprising either 0.2% to 10% w/w residual water or a mixture of water ethanol, 1-96% w/w orlistat, 3.7 to 98.7% maltodextrin and 0.1 to 95% w/w of one or more pharmaceutically acceptable excipients or 0.2% to 10% w/w residual isopropyl alcohol, 1 to 98.8% w/w oseltamivir and 1 to 98.8% w/w polymethacrylate.
Patent NZ-523274-A (NZ)
Title: Co-expression of recombinant proteins via an expression vector comprising a nucleic acid encoding a non-proteolytic analogue of a Hin47 protein of a strain of Haemophilus
Inventor: LOOSMORE SHEENA M
IPC: C07K14/285
Filed: 2001-05-03
Abstract: Expression vectors are described which permit the recombinant expression of proteins which essentially contain, in addition to nucleic acid encoding the recombinant protein, nucleic acid encoding a non-proteolytic analog of Haemophilus Hin47 protein, with or without leader sequence, or nucleic acid encoding high molecular weight proteins of non-typeable Haemophilus, which are hmwB, hmwC or hmwBC.
Patent NZ-525655-A (NZ)
Title: A device for use with dispensing machines, the device being capable of delivering prizes (gaming machine)
Inventor: REOBASCO JOSE MARIA DIONISIO
IPC: G07F9/00
Filed: 2003-05-02
Abstract: A promotion device attachable to a product and/or service dispensing machine includes a prize viewing screen, a dispensing slot, and actuating means comprising at least one push button for actuating the device. During an actuating cycle the device is commanded by an algorithm consisting of a random routine for delivering prizes, a program using a configuration of parameters, and an option for maintenance staff to access statistical information and adjust the parameters which comprise at least the number of prizes delivered by the device.
Patent NZ-528960-A (NZ)
Title: Novel azoles having an insecticidal action
Inventor: JESCHKE PETER
IPC: A01N43/78
Filed: 2002-04-10
Abstract: Heterocyclic azole compounds, methods for the production thereof, and their use as pesticides, particularly for controlling animal pests are disclosed.
Patent NZ-537627-A (NZ)
Title: Modafinil pharmaceutical compositions
Inventor: HEACOCK CRAIG
IPC: A61P25/00
Filed: 2003-07-11
Abstract: Disclosed is a pharmaceutical composition, comprising two or more portions of solid modafinil particles from a bulk batch of modafinil, wherein each portion has a bounded particle size range and wherein one or more particles size ranges present in the bulk batch are not represented in the pharmaceutical composition. Also disclosed are processes for preparing dosage form of modafinil, comprising more than 5% of modafinil particles having diameters greater than 200 microns, less than 95% of the modafinil particles in the dosage from having diameters less than 200 microns.
Patent NZ-537822-A (NZ)
Title: Glass repair apparatus and method therefore
Inventor: DAVIES CHRISTOPHER
IPC: B25B3/00
Filed: 2003-08-01
Abstract: A windscreen heater is used for heating a windscreen prior to and/or during resin repair. The heated windscreen promotes the flow of resin to repair the windscreen. The device is mounted to the windscreen and has a port enabling viewing of a target zone of the windscreen. A heater element is positioned in the region of the port in order to effect heating of the windscreen. The heater may an annular silicone mat or pad. A thermostat and thermometer are provided.
Patent NZ-538782-A (NZ)
Title: Methods for regulating transcription by targeting quadruplex DNA
Inventor: EBBINGHAUS SCOT W
IPC: C07D487/22
Filed: 2003-08-20
Abstract: Provided is a method for identifying a molecule that modulates gene transcription, which comprises providing a quadruplex DNA and a candidate molecule, wherein the quadruplex DNA comprises the nucleotide sequence (GGA)4 or the nucleotide sequence (GGA)3GG, and G is guanine and A is adenine, and the quadruplex DNA is in a heptad-tetrad conformation; contacting the quadruplex DNA with the candidate molecule; and determining the presence or absence of an interaction between the candidate molecule and the quadruplex DNA, whereby the candidate molecule that interacts with the quadruplex DNA is identified as the molecule that modulates gene transcription. Further provided are specific short DNA sequences to be used. Also provided is a complementary method of identifying a nucleotide sequence capable of forming a quadruplex structure using a quadruplex interacting agent, which can be TMPyP4 or telomestatin.
Patent NZ-542275-A (NZ)
Title: Herbicidal mixtures based on 3-phenyluracils
Inventor: ZAGAR CYRILL
IPC: A01N43/54
Filed: 2004-03-05
Abstract: Disclosed is a herbicidal mixture comprising 3-Phenyluracils of the formula (I) in which the variables R1 - R7 are as defined herein: R1 is methyl or NH2; R2 is C1-C2-haloalkyl; R3 is hydrogen or halogen; R4 is halogen or cyano; R5 is hydrogen; R6, R7 are identical or different, C1-C6-alkyl radicals, including their agriculturally acceptable salts; and at least one further herbicide B selected from the group consisting of: 4-hydroxy-3-{[2-methyl-6-(trifluoromethyl)-3-pyridinyl]carbonyl}bicyclo[3.2.1]oct-3-en-2-one, 4-hydroxy-3{[2-(2-methoxyethoxy)methyl-6-(trifluoromethyl)-3-pyridinyl]carbonyl}bicyclo[3.2.1]oct-3-en-2-one, and 4-hydroxy-3-[4-(methylsulfonyl)-2-nitrobenzoyl]bicyclo[3.2.1]oct-3-en-2-one; and optionally at least one safener C, selected from the group consisting of benoxacor, cloquintocet, cyometrinil, dichlormid, dicyclonon, dietholate, fenchlorazole, fenclorim, flurazole, fuxofenim, flurilazole, isoxadifen, mefenpyr, mephenate, naphthalic anhydride, 2,2,5-trimethyl-3-(dichloracetyl-1,3-oxazolidine (R-29148), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (AD-67, MON 4660) and oxabetrinil.
Patent NZ-545158-A (NZ)
Title: 2-Amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
Inventor: PERNI ROBERT B
IPC: C07K5/06
Filed: 2004-09-07
Abstract: Disclosed are pyrazine functionalised peptide derivatives of formula I: wherein: Ar is a five to ten membered aromatic ring having up to 4 heteroatoms selected from O, S, N(H), SO, and SO2; W is -C(=O)C(=O)-R6, or -C(=O)C(=O)-N(R6)2; T is an optionally substituted pyrazine moiety, and the other substituents are defined herein. Also disclosed is the use of a compound as defined above for the manufacture of a medicament for inhibiting the activity of a serine protease such as an HCV NS3 protease.
Patent NZ-549795-A (NZ)
Title: Dairy platform measurement systems and methods
Inventor: NILSON ROSS RICHARD
Filed: 2006-09-08
Abstract: A method and system for determining a stall position in a rotating dairy platform is provided. The method includes the steps of determining the orientation of the platform using a compass, and determining the stall position from a known relationship between stall position and platform orientation. A system including a compass arranged to provide an indication of the orientation of the platform, and a processor arranged to determine the stall position from a known relationship between stall position and platform orientation is also disclosed.
Patent NZ-550173-A (NZ)
Title: Game system
Inventor: UEMURA HIROSHI
IPC: A63F13/44
Filed: 2005-04-27
Abstract: A game system comprises a code reading means for reading in a code recorded in a card; a character generating means for generating a character, based on a combination of a plurality of codes read in by the reading means; and a character evaluating means for evaluating the generated character. The game system further comprises a memory means for storing at least base character data which are a base for the generated character, first part data for forming a part of the character, which corresponds to a first code, and a plurality of second part data for forming other parts of the character, which correspond to a second code. The character generating means includes a base character image generating means for reading out the base character data and generating a base character image; a first part changing means which, when the first code is read in, reads out the first part data corresponding to the first code from the memory means and changes a part of the base character data by the read out first part data; a second part changing means which, when the second code is read in, selects and reads out, out of the plurality of second part data, one second part data corresponding to the second code and changes another part of the base character image by the second part data; a third part changing means which, when the second code is read again, selects and reads out one second part data out of the plurality of second part data other than the second part data selected by the second part changing means, and changes another part of the base character image by the selected second part data; and a character image generating means for generating a character image, based on the character data changed by at least any one of the first part changing means, the second part changing means and the third part changing means.
Patent NZ-551961-A (NZ)
Title: Air decontamination device and method using a non-thermal plasma filter to remove contaminants and an aromatic hydrocarbon to breakdown ozone
Inventor: MOLE ALAN
IPC: B01D53/86
Filed: 2005-06-29
Abstract: A method of decontaminating air is disclosed. The steps comprise directing an air stream to be decontaminated through a non-thermal plasma filter 22 so that free radicals are produced by which contaminants in the air stream are neutralised. The ozone in the air stream output from the non-thermal plasma filter is then broken down with the breakdown being accelerated by subjecting the air stream to ultra-violet radiation and exposure to a catalyst 26. Then a hydrocarbon having a carbon-carbon double bond is introduced into the air stream to preferentially react with any residual ozone. The air stream thus becomes suitable for human exposure and a free-radical cascade is produced.
Patent NZ-553937-A (NZ)
Title: Substituted bicyclic imidazo-3-ylamine compounds
Inventor: KUHNERT SVEN
Filed: 2005-09-08
Abstract: Disclosed is a substituted bicyclic imidazo-3-yl-amine compound of the general formula I in which A1 denotes a nitrogen atom or a C-R1a group, A2 denotes a nitrogen atom or a C-R2a group, A3 denotes a nitrogen atom or a C-R3a group, A4 denotes a nitrogen atom or a C-R4a group, M1 denotes an aryl or heteroaryl residue, which may be substituted with at least one further substituent and/or fused with an unsubstituted or at least monosubstituted mono- or polycyclic ring system, M2 denotes an aryl or heteroaryl residue, which is unsubstituted or at least monosubstituted and optionally fused with an unsubstituted or at least monosubstituted mono- or polycyclic ring system and wherein the rest of the substituents are disclosed within the specification, in each case in the form of one of a pure stereoisomer thereof, a racemate thereof in the form of a mixture of stereoisomers, in any desired mixing ratio, or in each case in the form of a corresponding salt or in each case in the form of a corresponding solvate. Also disclosed is a use of at least one of the above compounds for the production of a medicament for the prevention and/or treatment of disorders and/or diseases which are mediated at least in part by mGluR5 receptors.
Patent NZ-561706-A (NZ)
Title: Self-contained and wireless monitoring device for a washing machine
Inventor: VEENING JAN EDUARD
IPC: D06F39/00
Filed: 2006-03-22
Abstract: A self-contained and wireless monitoring device is disclosed, which is for use in a washing machine to indicate shortage of detergent in said washing machine. The monitoring device comprises a sensor arranged to monitor detergent concentration in washing liquid of a washing machine and to provide an alarm signal when the monitored detergent concentration is below a target value. The monitoring device is capable of floating in the washing liquid and comprises signalling means for indicating a shortage of detergent in response to an alarm signal. Also disclosed is a package containing such a monitoring device and a method for indicating shortage of detergent.